{"disease":{"id":"nafld-and-nash","name":"nafld and nash"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07241195","title":"A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"The Affiliated Hospital of Hangzhou Normal University","has_results":false},{"nct_id":"NCT03082703","title":"Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Ashwani Singal,MD","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}